Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)

Kristian Reich, Howard Sofen, Yukari Okubo et al.|Journal of Dermatological Treatment|2016

Cited by 56